LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023
The Scrip Awards, now in its 19th year, celebrates the best innovations and achievements of the international biopharma industry.
- The Scrip Awards, now in its 19th year, celebrates the best innovations and achievements of the international biopharma industry.
- The award for Clinical Advance of the Year recognizes the success of a new drug product in a clinical trial that is expected to lead to an advance in healthcare.
- It was awarded for the success of the Phase III Clarity AD study of LEQEMBI.
- Eisai and Biogen deeply appreciate the cooperation of people living with AD and healthcare professionals who participated in LEQEMBI's clinical studies.